Holen Sie sich die Stockscreener-App
1.48
3.50%
0.05
Handel nachbörslich:
1.53
0.05
+3.38%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt FBIO?
Forum
Prognose
Aktiensplit
Finanzdaten der Fortress Biotech Inc-Aktie (FBIO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
34.67%
13.03
|
19.95 | 34.75 | 17.39 | 12.43 |
| Cost Of Revenue |
13.32%
6.816
|
6.015 | 6.429 | 7.767 | 6.449 |
| Gross Profit |
55.39%
6.214
|
13.93 | 28.32 | 9.619 | 5.98 |
Operating Expenses
|
27.53%
42.78
|
33.55 | 42.08 | 59.72 | 64.85 |
| Benefits Costs and Expenses |
7.21%
52.05
|
48.55 | 45.34 | 76.69 | 67.57 |
| Costs And Expenses |
25.37%
49.60
|
39.56 | 48.51 | 67.49 | 71.30 |
| Operating Income/Loss |
86.43%
-36.57
|
-19.61 | -13.76 | -50.10 | -58.87 |
| Nonoperating Income/Loss |
72.67%
-2.457
|
-8.991 | 3.175 | -9.196 | 3.722 |
| Income/Loss From Continuing Operations Before Tax |
36.42%
-39.02
|
-28.61 | -10.58 | -59.30 | -55.15 |
| Income Tax Expense/Benefit |
100.00%
-
|
0.358 | 0.141 | - | - |
| Income/Loss From Continuing Operations After Tax |
34.73%
-39.02
|
-28.96 | -10.72 | -59.30 | -55.15 |
|
Net Income/Loss
|
34.64%
-39.02
|
-28.98 | -10.72 | -59.30 | -55.15 |
| Preferred Stock Dividends And Other Adjustments |
15.24%
2.314
|
2.008 | 2.008 | 2.008 | - |
| Attributable To Noncontrolling Interest |
19.80%
-23.61
|
-19.70 | -5.679 | -34.52 | -33.61 |
| Basic Average Shares |
1,849%
17.15
|
0.8799 | 7.4987 | 110.66 | 101.89 |
| Basic Earnings Per Share |
94.34%
-1.03
|
-0.53 | -0.94 | -0.24 | -0.23 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
15.24%
2.314
|
2.008 | 2.008 | 2.008 | - |
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):